Boston-based Entrada Therapeutics, a biotech firm developing treatments for diseases through innovative delivery methods referred to as intracellular therapeutics, is expanding and relocating its Boston office. The firm signed a lease for 81,442 square feet of office space at the Innovation and Design Building in Boston's downtown Seaport District to serve as its new corporate headquarters.
Biotech Firm Expanding, Relocating Boston Office
Entrada Therapeutics Signs New Lease at the Innovation and Design Building in Seaport District
RELATED ARTICLES
This news story is available exclusively to CoStar subscribers.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
IN THIS ARTICLE
- Companies
- Entrada Therapeutics
Manufacturing
- Related Beal
Real Estate